[{"orgOrder":0,"company":"NordicCan","sponsor":"Entourage Health","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"","productType":"Small molecule","year":"2023","type":"Not Applicable","leadProduct":"Cannabidiol","moa":"","graph1":"Neurology","graph2":"Approved","graph3":"NordicCan","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"","sponsorNew":"NordicCan \/ NordicCan","highestDevelopmentStatusID":"12","companyTruncated":"NordicCan \/ NordicCan"}]

Find Clinical Drug Pipeline Developments & Deals by NordicCan

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Medlab Asia & Asia Health
                          Not Confirmed
                          Medlab Asia & Asia Health
                          Not Confirmed

                          Details : Starseed continues to solidify its position as an industry leader leveraging its innovative medical cannabis products to include unique CBD chewing gum. Cannabis-infused gum is made using CBD isolate in partnership with NordicCan.

                          Brand Name : Starseed

                          Molecule Type : Small molecule

                          Upfront Cash : Not Applicable

                          March 27, 2023

                          Lead Product(s) : Cannabidiol

                          Therapeutic Area : Neurology

                          Highest Development Status : Approved

                          Recipient : Entourage Health

                          Deal Size : Not Applicable

                          Deal Type : Not Applicable

                          blank